Glenmark Pharmaceuticals update on repurchase of bonds

Glenmark Pharmaceuticals announced the repurchase bonds aggregating principle amount of U.S.$86,500,000 through J.P. Morgan Securities plc and MUFG Securities Asia (the Dealer Managers) in the open market (the Transaction).

On the Settlement Date, the Company will acquire the Offered Bonds from the Dealer Managers. Offered Bonds will be cancelled by the Company on the Settlement Date. Following settlement of the Transaction, U.S.$113,500,000 in aggregate principal amount of Bonds will remain outstanding.

Powered by Capital Market - Live News